-
hcup-us.ahrq.gov/reports/statbriefs/sb169-Asthma-Trends-Hospital-Stays.jsp
January 01, 2014 - 97.6
99.2
Not metropolitan or micropolitan
104.0
110.0
Location of inpatient treatment … contain measures of potentially preventable hospitalizations for children for asthma, gastroenteritis, diabetes … However, if a patient received long-term care, rehabilitation, or treatment for psychiatric or chemical … Location of inpatient treatment
Location is based on the region of the treatment hospital and is one
-
www.ahrq.gov/downloads/pub/advances/vol2/Schiff.pdf
January 01, 2005 - in an
outpatient clinic
Blood glucoses meeting criteria for DM with no diagnosis
of diabetes in … for abnormal results, such as elevated
thyroid stimulating hormone [TSH], unaddressed by thyroxin therapy … Case 4
A 50-year-old woman with a past history diabetes and alcohol and IV drug
abuse, presents with … ultrasound was initially interpreted as being “positive,” illustrates the pitfalls of
taking irreversible therapeutic … Risk management issues in glaucoma
diagnosis and treatment.
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Schiff.pdf
January 01, 2005 - in an
outpatient clinic
Blood glucoses meeting criteria for DM with no diagnosis
of diabetes in … for abnormal results, such as elevated
thyroid stimulating hormone [TSH], unaddressed by thyroxin therapy … Case 4
A 50-year-old woman with a past history diabetes and alcohol and IV drug
abuse, presents with … ultrasound was initially interpreted as being “positive,” illustrates the pitfalls of
taking irreversible therapeutic … Risk management issues in glaucoma
diagnosis and treatment.
-
meps.ahrq.gov/data_files/publications/st255/stat255.shtml
August 01, 2009 - payments from Medicaid/SCHIP, other miscellaneous Federal sources (Indian Health Service, military treatment
-
psnet.ahrq.gov/node/49396/psn-pdf
April 01, 2003 - Antipsychotic treatment
lowers the seizure threshold and could have increased the severity and/or frequency
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_disposition-comments.pdf
August 12, 2016 - The authors might also note that there have been
remarkable changes in outcome measurements and treatment … that further attention might be given to the potential secular influences of
outcome assessment and treatment … Major CVD risk factors
can also consider diabetes. … Diabetes was considered as
an at-risk population. … But
diabetes is not a CVD
outcome, nor was it
considered to be a standard
CVD intermediate outcome
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
January 01, 2023 - Intervention C Intervention C, Dose Received (Mean) Intervention D Intervention D, Dose Received (Mean) Treatment … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - Intervention C Intervention C, Dose Received (Mean) Intervention D Intervention D, Dose Received (Mean) Treatment … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
January 01, 2022 - Intervention C Intervention C, Dose Received (Mean) Intervention D Intervention D, Dose Received (Mean) Treatment … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
January 01, 2022 - Intervention C Intervention C, Dose Received (Mean) Intervention D Intervention D, Dose Received (Mean) Treatment … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/advanced-care-decision-aids_technical-brief.pdf
July 01, 2014 - Intravenous therapies can be
initiated and maintained in various settings. … and likelihood of pain or loss of function in
order to decide for or against future life-prolonging therapies … But it
does not include values clarification exercises, education about medical conditions/treatments … Without data-rich decision
aids, patients with early Alzheimer’s might mistakenly believe there is therapeutic … : The case of diabetes.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/ssi/ssiapu.pptx
September 18, 2011 - order #8
ADMIT_SRC
ICU_ADMIT
INPAT_SURG
OUTPAT_SURG
AGE
BMI
CA_HX
CH_KIDNEY_DX
CH_LUNG_DX
COPD_HX
DIABETES … Indicative of need for hospitalization for post operative wound treatment. … preoperative risk factor, this finding was indicative of the need for hospitalization for post operative wound treatment
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2016_Severity.PDF
January 01, 2016 - 12,586 0.07%
405: Other procedures for endocrine, nutritional & metabolic disorders 4,155 0.02%
420: Diabetes … dependence, left against medical advice 28,852 0.17%
772: Alcohol & drug dependence w rehab or rehab/detox therapy … 0.68%
776: Other drug abuse & dependence 16,660 0.10%
791: O.R. procedure for other complications of treatment … reactions 14,309 0.08%
812: Poisoning of medicinal agents 100,501 0.58%
813: Other complications of treatment
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q4_Severity.PDF
October 31, 2017 - 3,531 0.08%
405: Other procedures for endocrine, nutritional & metabolic disorders 986 0.02%
420: Diabetes … dependence, left against medical advice 6,903 0.16%
772: Alcohol & drug dependence w rehab or rehab/detox therapy … 0.66%
776: Other drug abuse & dependence 3,905 0.09%
791: O.R. procedure for other complications of treatment … reactions 3,428 0.08%
812: Poisoning of medicinal agents 25,782 0.60%
813: Other complications of treatment
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2006_MaskedStats_Severity.PDF
January 01, 2006 - DEPENDENCE, LEFT AGAINST MEDICAL ADVICE 11751 0.15
772: ALCOHOL & DRUG DEPENDENCE W REHAB OR REHAB/DETOX THERAPY … PROC W MCC 761 0.01
2950: DIABETES WO CC 28347 0.35
2951: DIABETES W CC 34118 0.42
2952: DIABETES … WO CC 5871 0.07
4521: COMPLICATIONS OF TREATMENT W CC 9265 0.11
4522: COMPLICATIONS OF TREATMENT W … insipidus 436 0.01
END04: Diabetes Mellitus Type 1 32283 0.40
END05: Diabetes Mellitus Type 2 and … 1366 0.02
OTH85: Encounter for Preventive Health Services 2346 0.03
OTH86: Encounter for Radiation Therapy
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_SEVERITY.PDF
January 01, 2004 - DEPENDENCE, LEFT AGAINST MEDICAL ADVICE 11147 0.14
772: ALCOHOL & DRUG DEPENDENCE W REHAB OR REHAB/DETOX THERAPY … PROC W MCC 672 0.01
2950: DIABETES W/O CC 28740 0.36
2951: DIABETES W CC 31070 0.39
2952: DIABETES … W/O CC 5977 0.07
4521: COMPLICATIONS OF TREATMENT W CC 8557 0.11
4522: COMPLICATIONS OF TREATMENT … insipidus 321 0.00
END04: Diabetes Mellitus Type 1 44455 0.56
END05: Diabetes Mellitus Type 2 and … of
Total
OTH85: Encounter for Preventive Health Services 7994 0.10
OTH86: Encounter for Radiation Therapy
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2005_SummaryStats_SEVERITY.PDF
January 01, 2005 - DEPENDENCE, LEFT AGAINST MEDICAL ADVICE 9211 0.12
772: ALCOHOL & DRUG DEPENDENCE W REHAB OR REHAB/DETOX THERAPY … PROC W MCC 727 0.01
2950: DIABETES WO CC 28660 0.36
2951: DIABETES W CC 31430 0.39
2952: DIABETES … WO CC 5878 0.07
4521: COMPLICATIONS OF TREATMENT W CC 8624 0.11
4522: COMPLICATIONS OF TREATMENT W … insipidus 432 0.01
END04: Diabetes Mellitus Type 1 33412 0.42
END05: Diabetes Mellitus Type 2 and … 1536 0.02
OTH85: Encounter for Preventive Health Services 2881 0.04
OTH86: Encounter for Radiation Therapy
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_SEVERITY.PDF
January 01, 2003 - DEPENDENCE, LEFT AGAINST MEDICAL ADVICE 8234 0.10
772: ALCOHOL & DRUG DEPENDENCE W REHAB OR REHAB/DETOX THERAPY … PROC W MCC 597 0.01
2950: DIABETES W/O CC 28252 0.35
2951: DIABETES W CC 29178 0.37
2952: DIABETES … W/O CC 5950 0.07
4521: COMPLICATIONS OF TREATMENT W CC 7759 0.10
4522: COMPLICATIONS OF TREATMENT … insipidus 308 0.00
END04: Diabetes Mellitus Type 1 43646 0.55
END05: Diabetes Mellitus Type 2 and … 1415 0.02
OTH85: Encounter for Preventive Health Services 5442 0.07
OTH86: Encounter for Radiation Therapy
-
www.ahrq.gov/es/patient-safety/settings/hospital/vtguide/guideref.html
July 01, 2018 - Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: … Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. … J Diabetes Science Tech 2008;2(3):349-56.
Maynard G, Morris T, Jenkins I, et al. … VTE, thrombophilia, antithrombotic therapy and pregnancy: antithrombotic therapy and prevention of thrombosis … Bed rest: a potentially harmful treatment needing more careful evaluation.
-
www.ahrq.gov/patient-safety/settings/hospital/vtguide/guideref.html
July 01, 2018 - Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: … Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. … J Diabetes Science Tech 2008;2(3):349-56.
Maynard G, Morris T, Jenkins I, et al. … VTE, thrombophilia, antithrombotic therapy and pregnancy: antithrombotic therapy and prevention of thrombosis … Bed rest: a potentially harmful treatment needing more careful evaluation.